国际中医中药杂志
國際中醫中藥雜誌
국제중의중약잡지
INTERNATIONAL JOURNAL OF TRIDITIONAL CHINESE MEDICINE
2012年
7期
591-593
,共3页
赖毛华%马红霞%刘华%宋兴华%丁涛%郑艳华
賴毛華%馬紅霞%劉華%宋興華%丁濤%鄭豔華
뢰모화%마홍하%류화%송흥화%정도%정염화
多囊卵巢综合征%脾肾阳虚%中医证型
多囊卵巢綜閤徵%脾腎暘虛%中醫證型
다낭란소종합정%비신양허%중의증형
Polycystic ovary syndrome%Spleen-kidney yang deficiency type%TCM syndrome
目的 探讨脾肾阳虚型多囊卵巢综合征(polycystic ovary syndrome,PCOS)本质,寻找客观化指标.方法 收集200例PCOS患者,经辨证分为脾肾阳虚组105例和非脾肾阳虚组95例,检测并比较两组患者的体重指数(BMI)、腰臀比(WHR)、卵泡刺激素(FSH)、黄体生成素(LH)、雌二醇(E2)、睾酮(T)性激素水平、空腹血糖(FPG)、空腹胰岛素(FINS)、餐后2h胰岛素(2 hINS)、胰岛素抵抗指数(HOMR-IR)在脾肾阳虚型与非脾肾阳虚型PCOS患者中的差异.结果 脾肾阳虚组BMI (24.4±2.8)、WHR (0.88±0.07)、LH/FSH (2.02±1.06)、E2 (55.84±23.87) pg/ml、HOMR-IR (2.95±1.52)、FINS(15.18±7.64) IU/ml、2hlNS (59.53±40.61) IU/ml均高于非脾肾阳虚组[分别为(22.2±2.2)、(0.80±0.06)、(3.50±1.80)、(45.82±21.31) pg/ml、( 1.90±1.50)、(9.93±6.59) IU/ml、(50.56±41.34) IU/ml],差异均有统计学意义(P均<0.05);但FSH、T激素水平比较,差异无统计学意义(FSH脾肾阳虚组(6.46±0.95) IU/L、FSH 非脾肾虚组=(6.40±1.16) IU/L;T脾肾阳虚组=(0.81±0.15) μg/L、T非脾肾阳虚组=(0.72±0.13)μg/L,P>0.05).结论 BMI、WHR、LH/FSH、E2、HOMR-IR、FINS、2 hINS指标可作为脾肾阳虚型PCOS的客观化参考指标.
目的 探討脾腎暘虛型多囊卵巢綜閤徵(polycystic ovary syndrome,PCOS)本質,尋找客觀化指標.方法 收集200例PCOS患者,經辨證分為脾腎暘虛組105例和非脾腎暘虛組95例,檢測併比較兩組患者的體重指數(BMI)、腰臀比(WHR)、卵泡刺激素(FSH)、黃體生成素(LH)、雌二醇(E2)、睪酮(T)性激素水平、空腹血糖(FPG)、空腹胰島素(FINS)、餐後2h胰島素(2 hINS)、胰島素牴抗指數(HOMR-IR)在脾腎暘虛型與非脾腎暘虛型PCOS患者中的差異.結果 脾腎暘虛組BMI (24.4±2.8)、WHR (0.88±0.07)、LH/FSH (2.02±1.06)、E2 (55.84±23.87) pg/ml、HOMR-IR (2.95±1.52)、FINS(15.18±7.64) IU/ml、2hlNS (59.53±40.61) IU/ml均高于非脾腎暘虛組[分彆為(22.2±2.2)、(0.80±0.06)、(3.50±1.80)、(45.82±21.31) pg/ml、( 1.90±1.50)、(9.93±6.59) IU/ml、(50.56±41.34) IU/ml],差異均有統計學意義(P均<0.05);但FSH、T激素水平比較,差異無統計學意義(FSH脾腎暘虛組(6.46±0.95) IU/L、FSH 非脾腎虛組=(6.40±1.16) IU/L;T脾腎暘虛組=(0.81±0.15) μg/L、T非脾腎暘虛組=(0.72±0.13)μg/L,P>0.05).結論 BMI、WHR、LH/FSH、E2、HOMR-IR、FINS、2 hINS指標可作為脾腎暘虛型PCOS的客觀化參攷指標.
목적 탐토비신양허형다낭란소종합정(polycystic ovary syndrome,PCOS)본질,심조객관화지표.방법 수집200례PCOS환자,경변증분위비신양허조105례화비비신양허조95례,검측병비교량조환자적체중지수(BMI)、요둔비(WHR)、란포자격소(FSH)、황체생성소(LH)、자이순(E2)、고동(T)성격소수평、공복혈당(FPG)、공복이도소(FINS)、찬후2h이도소(2 hINS)、이도소저항지수(HOMR-IR)재비신양허형여비비신양허형PCOS환자중적차이.결과 비신양허조BMI (24.4±2.8)、WHR (0.88±0.07)、LH/FSH (2.02±1.06)、E2 (55.84±23.87) pg/ml、HOMR-IR (2.95±1.52)、FINS(15.18±7.64) IU/ml、2hlNS (59.53±40.61) IU/ml균고우비비신양허조[분별위(22.2±2.2)、(0.80±0.06)、(3.50±1.80)、(45.82±21.31) pg/ml、( 1.90±1.50)、(9.93±6.59) IU/ml、(50.56±41.34) IU/ml],차이균유통계학의의(P균<0.05);단FSH、T격소수평비교,차이무통계학의의(FSH비신양허조(6.46±0.95) IU/L、FSH 비비신허조=(6.40±1.16) IU/L;T비신양허조=(0.81±0.15) μg/L、T비비신양허조=(0.72±0.13)μg/L,P>0.05).결론 BMI、WHR、LH/FSH、E2、HOMR-IR、FINS、2 hINS지표가작위비신양허형PCOS적객관화삼고지표.
Objective To explore the essence of polycystic ovary syndrome of spleen-kidney yang deficiency,and to investigate the objective standardization of TCM syndrome diagnosis of the disease.Methods Among the 200 PCOS patients,the Chinese medicine syndrome pattern was differentiated as spleen-kidney yang deficiency type (n=105 )and Non-spleen-kidney yang deficiency type (n=95).To measure and compare their levels ofBMI、WHR、sexual hormones、FINS、2 hINS,and HOMR-IR.Results The levels of BMI (24.4±2.8)、WHR (0.88±0.07)、LH/FSH (2.02±1.06)、E2 (55.84±23.87) pg/ml、HOMR-IR (2.95±1.52)、FINS (15.18±7.64) IU/ml、2hINS ( 59.53 ±40.61 ) IU/ml in the group of spleen-kidney yang deficiency type were obviously higher than those[ (22.2±2.2)、(0.80±0.06)、(3.50± 1.80)、(45.82±21.31) pg/ml、( 1.90± 1.50)、(9.93±6.59) IU/ml、(50.56±41.34) IU/ml respectively] in the group of Non-spleen-kidney yang deficiency type (P<0.05=,but T and FSH level showed no significant difference between two groups [FSH the group of spleen-kidney yang deficiency type=(6.46±0.95) IU/L、FSH the group of No-spleen-kidney yang deficiency type=(6.40±1.16) IU/L; T the group of spleen-kidney yang deficiency type=(0.81±0.15) μg/L、T the group of No-spleen-kidney yang deficiency type=(0.72±0.13) μg/L,P>0.05].Conclusion BMI、WHR、LH/FSH、E2、FINS、2HINS,and HOMR-IR could be used as objective index in identifying the difference in between spleen-kidney yang deficiency type and Non-spleen-kidney yang deficiency type.